Appetite loss in cancer, often referred to as cancer-related anorexia, is a common symptom experienced by individuals undergoing cancer treatment or living with advanced cancer. Reduced appetite can make it difficult to maintain adequate nutrition, leading to weight loss, fatigue, and reduced physical strength during treatment. For individuals whose symptoms remain difficult to manage with conventional approaches, medical cannabis is increasingly being explored as a potential option that may help influence appetite regulation and support nutritional intake. Leafease offers carefully developed medical cannabis solutions designed to provide a regulated and balanced approach for individuals seeking additional support in managing appetite loss in cancer.
of patients with advanced cancer experience appetite loss during the course of their illness.
of patients experience significant weightloss linked to reduced appetite.
Of patients undergoing chemotherapy report appetite changes affecting food intake
If these symptoms sound familiar and continue despite conventional treatments, you can quickly find out whether you may be eligible for medical cannabis treatment through our simple online assessment.
The treatment pathway for appetite loss in cancer usually begins with a clinical assessment where healthcare professionals evaluate nutritional status, weight changes, and possible causes of reduced appetite. Conventional management may include dietary counselling, nutritional supplements, and strategies designed to increase calorie intake. In some cases, medications may be prescribed to help stimulate appetite or manage symptoms that interfere with eating, such as nausea or digestive discomfort. Multidisciplinary care involving oncologists and dietitians may also help improve nutritional outcomes. For individuals whose symptoms remain difficult to manage despite these approaches, medical cannabis may also be explored under specialist supervision as an alternative option for symptom relief, with LeafEase providing carefully formulated medical cannabis solutions to support patients seeking additional management options.
Appetite loss in cancer can occur due to several physical and psychological factors associated with the disease or its treatment.
These factors may reduce interest in food and make it difficult for individuals to maintain regular eating patterns.
Find out if you may be eligible for Appetite Loss in Cancer medical cannabis treatment here.
Medical cannabis may help support appetite regulation by interacting with the body’s endocannabinoid system, which plays a role in controlling hunger, metabolism, and digestive responses. Cannabinoids such as CBD and THC may influence pathways involved in appetite stimulation and gastrointestinal comfort. Some individuals also report improvements in sleep and overall wellbeing when symptoms are better managed. When prescribed under specialist supervision, medical cannabis may be considered as an alternative or complementary option for individuals whose cancer-related appetite loss remains difficult to manage with conventional treatments.
Reference: https://pubmed.ncbi.nlm.nih.gov/15336334/
Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/
At LeafEase, treatment is delivered under specialist supervision to ensure every patient is carefully assessed and supported throughout their care. Our personalised approach helps you explore medical cannabis as a regulated, clinically guided option for managing appetite loss in cancer.
Medical cannabis may help manage appetite loss in cancer, but some individuals may experience side effects depending on dosage, formulation, and personal response.
Most side effects are typically mild, temporary, and carefully monitored to ensure treatment remains safe and well tolerated.
Find out whether medical cannabis may be a suitable treatment option for Appetite Loss in Cancer
Simply submit your questions, and we’ll do our best to address them promptly and thoroughly. Your health is our priority, and we’re here to support you every step of the way.
Specialist clinicians usually assess a patient’s nutritional status, weight changes, treatment history, and current cancer therapies before considering medical cannabis as part of a symptom management plan.
Doctors may evaluate the severity of appetite loss, previous treatment responses, potential medication interactions, and the patient’s overall health when determining whether cannabis-based therapy may be appropriate.
Specialist clinicians may prescribe regulated products such as cannabis oils or capsules depending on the patient’s symptoms and the treatment plan developed during consultation.
Clinicians generally begin with a carefully monitored starting dose and adjust the formulation gradually based on symptom response and individual tolerance.
Patients are usually reviewed during follow-up consultations where clinicians assess appetite changes, weight stability, and overall treatment tolerance.
Specialist clinicians may consider cannabis-based therapies alongside dietary support strategies and nutritional counselling to help support adequate food intake.
A comprehensive clinical evaluation helps clinicians assess treatment goals, nutritional needs, and potential risks before incorporating cannabis-based medicines into a personalised care plan.
